Skip to main content
Springer logoLink to Springer
. 2023 Sep 7;33(8):3735–3736. doi: 10.1007/s00590-023-03709-5

Correction to: Update on the efficacy and safety of intravenous tranexamic acid in hip fracture surgery: a systematic review and meta‑analysis

Shahid Miangul 1,2,, Timothy Oluwaremi 1,2, Joe El Haddad 1,2, Maamoun Adra 1,2, Nathan Pinnawala 1,2, Hayato Nakanishi 1,2, Reem H Matar 1,2,3, Christian A Than 1,2,4, Thomas M Stewart 5
PMCID: PMC10651693  PMID: 37679423

Correction to: European Journal of Orthopaedic Surgery & Traumatology (2023) 33:2179–2190 https://doi.org/10.1007/s00590-022-03387-9

The original version of this article unfortunately contained a mistake. In Table 3, incorrect numerical values were inserted into the table cells “Incidence of Post-Operative DVT (n)” and “Incidence of Post-Operative PE (n)”, which resulted in a discrepancy between the data presented in Table 3.

Table 3.

Intraoperative and postoperative outcomes

Outcomes Placebo Group TXA group
Total blood loss (mL) 807.30 ± 389.75 618.91 ± 282.72
Hidden blood loss (mL) 619.47 ± 311.93 438.86 ± 265.61
Intraoperative blood loss (mL) 136.09 ± 86.19 103.60 ± 75.75
Transfusion rate (n) 456 (n = 1118) 232 (n = 1112)
Post-operative Hb level day 1 (g/L) 95.55 ± 28.17 104.42 ± 13.72
Post-operative Hb level day 3 (g/L) 84.30 ± 17.79 91.46 ± 14.74
Incidence of post-operative DVT (n) 28 (n = 830) 34 (n = 831)
Incidence of post-operative PE (n) 9 (n = 702) 7 (n = 689)
Length of hospital stay (Days) 11.19 ± 5.80 10.13 ± 4.11
Operation time (Minutes) 80.30 ± 32.07 79.99 ± 30.96

DVT deep vein thrombosis, Hb hemoglobin, PE pulmonary embolism

The corrected Table 3 should read as:

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from European Journal of Orthopaedic Surgery & Traumatology are provided here courtesy of Springer

RESOURCES